These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 17255310)

  • 1. Osteoclasts: what do they do and how do they do it?
    Teitelbaum SL
    Am J Pathol; 2007 Feb; 170(2):427-35. PubMed ID: 17255310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
    Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
    Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M-CSF mediates TNF-induced inflammatory osteolysis.
    Kitaura H; Zhou P; Kim HJ; Novack DV; Ross FP; Teitelbaum SL
    J Clin Invest; 2005 Dec; 115(12):3418-27. PubMed ID: 16294221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
    Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
    Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.
    Faccio R; Zou W; Colaianni G; Teitelbaum SL; Ross FP
    J Cell Biochem; 2003 Dec; 90(5):871-83. PubMed ID: 14624447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talin1 and Rap1 are critical for osteoclast function.
    Zou W; Izawa T; Zhu T; Chappel J; Otero K; Monkley SJ; Critchley DR; Petrich BG; Morozov A; Ginsberg MH; Teitelbaum SL
    Mol Cell Biol; 2013 Feb; 33(4):830-44. PubMed ID: 23230271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-associated molecules and signalling cross talking in osteoclast cytoskeleton regulation.
    Kong L; Wang B; Yang X; He B; Hao D; Yan L
    J Cell Mol Med; 2020 Mar; 24(6):3271-3281. PubMed ID: 32045092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical and non-canonical pathways of osteoclast formation.
    Knowles HJ; Athanasou NA
    Histol Histopathol; 2009 Mar; 24(3):337-46. PubMed ID: 19130404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology.
    Ross FP; Teitelbaum SL
    Immunol Rev; 2005 Dec; 208():88-105. PubMed ID: 16313343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IGF-I signaling in regulating osteoclastogenesis.
    Wang Y; Nishida S; Elalieh HZ; Long RK; Halloran BP; Bikle DD
    J Bone Miner Res; 2006 Sep; 21(9):1350-8. PubMed ID: 16939393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclasts; culprits in inflammatory osteolysis.
    Teitelbaum SL
    Arthritis Res Ther; 2006; 8(1):201. PubMed ID: 16356195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of osteoporosis development in patients with rheumatoid arthritis].
    Matuszewska A; Szechiński J
    Postepy Hig Med Dosw (Online); 2014 Feb; 68():145-52. PubMed ID: 24491906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammation and osteoclasts].
    Yokota K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):367-376. PubMed ID: 29238019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of osteoclast function and pathways.
    Broadhead ML; Clark JC; Dass CR; Choong PF; Myers DE
    Expert Opin Ther Targets; 2011 Feb; 15(2):169-81. PubMed ID: 21204734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis.
    Lin YY; Jean YH; Lee HP; Lin SC; Pan CY; Chen WF; Wu SF; Su JH; Tsui KH; Sheu JH; Sung PJ; Wen ZH
    Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28067799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.